EPISODE · Feb 5, 2026 · 9 MIN
今天3分钟我们来聊聊全球首例！衰老逆转技术人体试验获批
from 源于细胞BioInsid的个人播客
2026年1月28日，美国Life Biosciences公司宣布其ER-100获FDA批准开展人体试验，这是全球首个衰老逆转技术人体试验。该技术基于表观遗传重编程，通过控制表达山中因子中的三种转录因子，恢复衰老或受损细胞年轻状态，首试将针对开放角青光眼和非动脉前方缺血性视神经病变。 前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊全球首例！衰老逆转技术人体试验获批
0:00
9:37
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 9 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on February 5, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!